What is the difference between AMINOCAPROIC ACID and TRANEXAMIC ACID?

AMINOCAPROIC ACID and TRANEXAMIC ACID are both Thrombolytics, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Is Aminocaproic Acid the same as tranexamic acid?

No. Aminocaproic Acid (AMINOCAPROIC ACID) and tranexamic acid (TRANEXAMIC ACID) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, AMINOCAPROIC ACID or TRANEXAMIC ACID?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from AMINOCAPROIC ACID to TRANEXAMIC ACID?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

AMINOCAPROIC ACID vs TRANEXAMIC ACID

Compare AMINOCAPROIC ACID (Aminocaproic Acid) and TRANEXAMIC ACID (tranexamic acid) — clinical data, side effects, and patient experiences.

AMINOCAPROIC ACID

Aminocaproic Acid · Thrombolytic

How it works

Thrombolytic agent

Approved for

INDICATIONS AND USAGE Aminocaproic Acid Injection is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life-threatening situations

fresh whole blood transfusions

fibrinogen infusions

and other emergency measures may be required. Fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures)

IntravenousTablet

TRANEXAMIC ACID

tranexamic acid · Thrombolytic

How it works

12.1 Mechanism of Action Tranexamic acid is a synthetic lysine amino acid derivative, which diminishes the dissolution of hemostatic fibrin by plasmin. In the presence of tranexami...

Approved for

1 INDICATIONS AND USAGE Tranexamic acid injection

IntravenousTablet

Quick Comparison

AMINOCAPROIC ACIDTRANEXAMIC ACID

Drug Class

Thrombolytic

Route

Intravenous

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

AMINOCAPROIC ACID

Drug Not Working

1-10%

Low Blood Pressure

1-10%

Falls

0.1-1%

Fever

0.1-1%

TRANEXAMIC ACID

Drug Not Working

>10%

Fever

1-10%

Nausea

1-10%

Diarrhea

1-10%

Vomiting

1-10%

Low Blood Pressure

1-10%

Shortness of Breath

1-10%

Headache

0.1-1%

FDA Warnings

AMINOCAPROIC ACID

WARNINGS Aminocaproic Acid Injection, USP contains benzyl alcohol as a preservative
The administration of medications containing benzyl alcohol as a preservative to premature neonates has been associated with a fatal “Gasping Syndrome”
For this reason, aminocaproic acid should not be used in hematuria of upper urinary tract origin, unless the possible benefits outweigh the risk
Death was due to continued cerebrovascular hemorrhage

TRANEXAMIC ACID

5 WARNINGS AND PRECAUTIONS Risk of Thrombosis with Concomitant Use of Factor IX: Avoid concomitant use
1 ) Risk of Medication Errors Due to Incorrect Route of Administration: FOR INTRAVENOUS USE ONLY
1 Thromboembolic Risk Tranexamic acid injection is contraindicated in patients with active intravascular clotting
Tranexamic acid is an antifibrinolytic and may increase the risk of thromboembolic events

Clinical Trial Data

No head-to-head clinical studies found for AMINOCAPROIC ACID vs TRANEXAMIC ACID.

AMINOCAPROIC ACID vs TRANEXAMIC ACID: What You Should Know

Key Differences

Both AMINOCAPROIC ACID and TRANEXAMIC ACID belong to the Thrombolytic class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

AMINOCAPROIC ACID carries 4 FDA warnings. TRANEXAMIC ACID carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

AMINOCAPROIC ACID: DailyMed label · FAERS adverse events · ClinicalTrials.gov
TRANEXAMIC ACID: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

AMINOCAPROIC ACID vs TRANEXAMIC ACID

Compare AMINOCAPROIC ACID (Aminocaproic Acid) and TRANEXAMIC ACID (tranexamic acid) — clinical data, side effects, and patient experiences.

AMINOCAPROIC ACID

Aminocaproic Acid · Thrombolytic

How it works

Thrombolytic agent

Approved for

INDICATIONS AND USAGE Aminocaproic Acid Injection is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life-threatening situations

fresh whole blood transfusions

fibrinogen infusions

and other emergency measures may be required. Fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures)

IntravenousTablet

TRANEXAMIC ACID

tranexamic acid · Thrombolytic

How it works

12.1 Mechanism of Action Tranexamic acid is a synthetic lysine amino acid derivative, which diminishes the dissolution of hemostatic fibrin by plasmin. In the presence of tranexami...

Approved for

1 INDICATIONS AND USAGE Tranexamic acid injection

IntravenousTablet

Quick Comparison

AMINOCAPROIC ACIDTRANEXAMIC ACID

Drug Class

Thrombolytic

Route

Intravenous

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

AMINOCAPROIC ACID

Drug Not Working

1-10%

Low Blood Pressure

1-10%

Falls

0.1-1%

Fever

0.1-1%

TRANEXAMIC ACID

Drug Not Working

>10%

Fever

1-10%

Nausea

1-10%

Diarrhea

1-10%

Vomiting

1-10%

Low Blood Pressure

1-10%

Shortness of Breath

1-10%

Headache

0.1-1%

FDA Warnings

AMINOCAPROIC ACID

WARNINGS Aminocaproic Acid Injection, USP contains benzyl alcohol as a preservative
The administration of medications containing benzyl alcohol as a preservative to premature neonates has been associated with a fatal “Gasping Syndrome”
For this reason, aminocaproic acid should not be used in hematuria of upper urinary tract origin, unless the possible benefits outweigh the risk
Death was due to continued cerebrovascular hemorrhage

TRANEXAMIC ACID

5 WARNINGS AND PRECAUTIONS Risk of Thrombosis with Concomitant Use of Factor IX: Avoid concomitant use
1 ) Risk of Medication Errors Due to Incorrect Route of Administration: FOR INTRAVENOUS USE ONLY
1 Thromboembolic Risk Tranexamic acid injection is contraindicated in patients with active intravascular clotting
Tranexamic acid is an antifibrinolytic and may increase the risk of thromboembolic events

Clinical Trial Data

No head-to-head clinical studies found for AMINOCAPROIC ACID vs TRANEXAMIC ACID.

AMINOCAPROIC ACID vs TRANEXAMIC ACID: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.